E. Wasielewski

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

N. Girard, J. Blay, F. Galateau-Sallé, 2019, EBioMedicine.

Dual-Energy CT Perfusion of Invasive Tumor Front in Non-Small Cell Lung Cancers.

J. Remy, T. Flohr, M. Sedlmair, 2021, Radiology.

HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells

L. Willems, R. Louis, A. Scherpereel, 2022, Cancers.

Feasibility trial assessing intrapleural photodynamic therapy combined with pleurectomy/decortication then chemotherapy in malignant pleural mesothelioma patients

Serge Mordon, Camille Munck, Ecaterina Surmei-Pintilie, 2019, World Congress of the International Photodynamic Association.

[Tumour assessment criteria for immune checkpoint inhibitors].

E. Wasielewski, A. Cortot, 2018, Revue des maladies respiratoires.

Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma.

M. Copin, E. Patrucco, R. Chiarle, 2020, Lung cancer.

Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma

R. Louis, A. Scherpereel, E. Wasielewski, 2023, Frontiers in Immunology.

Abstract 663: Resistin mediates the immunoediting activity exerted by primary human macrophages towards mesothelioma cells

L. Willems, A. Scherpereel, E. Wasielewski, 2023, Cancer Research.

Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC).

G. Zalcman, F. Guisier, M. Wislez, 2023, Lung cancer.

Severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti-PD(L)1 and sotorasib therapy in KRASG12C-mutant lung cancer.

C. Mascaux, E. Wasielewski, V. Gounant, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Tumour assessment criteria for immune checkpoint inhibitors].

E. Wasielewski, A. Cortot, A. Cortot, 2018, Revue des maladies respiratoires.